InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: oneragman post# 182366

Thursday, 03/21/2019 3:44:54 PM

Thursday, March 21, 2019 3:44:54 PM

Post# of 428981

Assuming the trial was a success and given the unexpected and unprecedented RI trial results, I would think you could get an expanded label.


If BRAVE is successful, the only thing that should say on the Vascepa labelis:

"For anyone over age 50, period".

CVD + Alzheimer's would be like Google merging with Amazon.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News